Lataa...
Basal insulin secretion capacity predicts the initial response and maximum levels of beta‐hydroxybutyrate during therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin, in relation to weight loss
AIMS: To investigate predictors of the initial response of beta‐hydroxybutyrate (BHB) and maximum BHB (max‐BHB) values during long‐term therapy with the sodium‐glucose co‐transporter‐2 inhibitor tofogliflozin (TOFO), and to explore the association of the initial elevation of BHB with subsequent clin...
Tallennettuna:
| Julkaisussa: | Diabetes Obes Metab |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Blackwell Publishing Ltd
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6973158/ https://ncbi.nlm.nih.gov/pubmed/31608549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13890 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|